The master patient index software market in Asia Pacific is expected to grow from US$ 180.3 million in 2021 to US$ 371.2 million by 2028; it is estimated to grow at a CAGR of 10.9% from 2021 to 2028.
Healthcare IT solutions are enabling large-scale innovations in healthcare sector, which contribute to the improvement of service quality. Technologies such as telemedicine, mHealth, remote patient monitoring, behavioral health technologies, and consumer-driven digital health have significantly transformed fundamentals of care delivery. The positive outlook and acceptance for these advancements is likely to encourage companies to develop MPI software in greater numbers in the coming future. Infrastructure developments along with the adoption of automated healthcare IT solutions have drawn government support and investments toward healthcare digitalization. Moreover, the COVID-19 pandemic has created the need of additional investments for the establishment of the digital healthcare. The digitalization of processes in healthcare segment is emerging as a prominent trend that would propel the adoption of MPI software during the forecast period.
The COVID-19 pandemic has put a major strain on the health systems of many countries around the world. Testing capacity in many Asia Pacific countries was limited and of low quality in the initial days of the pandemic, which led to a surge in the COVID-19 cases. However, many countries, such as South Korea, Japan, and Singapore, were efficiently contained the situation through robust tracking and testing. Also, India has the second-highest number of cases in the world after the US. The increasing burden on existing healthcare systems and rising demand for advanced data collection and analysis technologies are expected to drive the Asia Pacific Master Patient index software market, even during the pandemic. In January 2021, BC Platforms, a significant clinical and genomic data management player, announced a collaboration with Japan-based RIKEN research institution and the Finnish Institute for Health and Welfare (‘THL’). Moreover, adoption of digitalization of the healthcare system, the growing preference for remote patient care in the developing countries in the region, and a more significant number of regulatory agencies laying stress on value and patient outcome, patient engagement is expected to increase adoption of the master patient index software in coming years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the master patient index software market. The Asia Pacific Master patient index software market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Asia Pacific Master Patient Index Software Market Segmentation
By Type
- Software
- Service
By Deployment
- Cloud-based
- On Premises
By Country
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Companies Mentioned
- McKESSON CORPORATION
- Oracle Corporation
- Wipro Limited
- Allscripts Healthcare Solutions, Inc.
- MEDITECH
- Intersystems Corporation
Asia Pacific Master Patient Index Software Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 180.3 Million |
Market Size by 2028 | US$ 371.2 Million |
Global CAGR (2021 - 2028) | 10.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Asia-Pacific
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















